Sarepta decision to halt Duchenne treatment continues to frustrate families; FDA reinstate a quarter of DOGE cuts; Contract research organizations report higher than expected pharma and biotech Q2 ...

John will offer his entrepreneurial and marketing insights on brand innovation to help healthcare marketers make a splash in a sea of change.

In a warning letter, the Food and Drug Administration said Glenmark Pharmaceuticals failed to properly investigate flaws with a generic drug that ProPublica found was linked to U.S. deaths.

With an eye on protecting consumers from those risks this summer, Band-Aid has launched its latest innovation: Waterproof ...

The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

Throughout the country, pediatricians say anxious parents are concerned about access to routine childhood immunizations, ...

Millions of people are expected to lose health insurance in the coming years as a result of the tax cut legislation Trump ...

Maine was among the first states to begin extensive water and soil testing and to try to limit further public exposure to ...

Measles can survive for up to two hours in the air in a space where an infected person has been, sickening up to 90% of ...

But now that a GOP-led Congress has approved $186 billion in cuts to the food assistance program through 2034, McLoyd, who ...

In honor of National Intern Day, medical marketing executives share their strategy for expanding young talent.